Actively Recruiting
Randomized Cluster Crossover Trial Comparing Aspirin and Low Molecular Weight Heparin to Prevent Blood Clots After Hip Fracture Surgery
Led by Queen Mary University of London · Updated on 2026-09-23
21194
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
The DIRECT study is investigating the best way to prevent blood clots in adults aged 60 and older who have broken their hip. It compares two common treatments aspirin, a pill, and low molecular weight heparin LMWH, which is given by injection. This large, randomized crossover trial aims to determine if aspirin can be a safe and cost-effective alternative to LMWH, which is currently the standard but can be difficult for patients to manage at home. Participants are treated according to the hospitals assigned standard treatment during set periods, either aspirin or LMWH. Aspirin is taken orally and is simpler and less costly, while LMWH requires daily injections for about 14 to 28 days. Hospitals switch between treatments during the study to allow fair comparison. The study uses data collected from national NHS databases, so participants do not need to attend extra visits or perform additional procedures. Throughout the study, information on blood clot events and death within 90 days will be gathered from NHS records. Researchers will also monitor bleeding events within 28 days. The study will evaluate which treatment better prevents blood clots with fewer side effects, using anonymized patient data to ensure privacy. The results aim to improve future care recommendations and reduce treatment burden for patients with hip fractures.
CONDITIONS
Brief Title
Delivery and Implementation of a Randomised Crossover Trial on Thrombosis
Research Team
N
Nkemjika S Abiakam, BSc, MRes, MSc, PhD
J
Jamila Kassam, BSc (Hons), MRes MCSP
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here